Menopause & Midlife

Does Hormone Therapy Cause Breast Cancer? What the Research Shows

By the Find Her Doctor editorial team · Updated November 1, 2026 · 5 min read

Hormone therapy's link to breast cancer depends on the type. Estrogen combined with a progestogen is associated with a small increase in breast cancer risk, mainly with use beyond a few years. Estrogen alone, used by people who've had a hysterectomy, did not raise breast cancer risk in the Women's Health Initiative and may have lowered it.

The Menopause Society describes the added risk from combined therapy as small in absolute terms. That's not the same as "no risk," and it's not the same as the scary headlines many people remember from the early 2000s. Here's how to put it in context for your own decision.

Why so many people are afraid of HRT

In 2002, part of the Women's Health Initiative (WHI), a large NIH-funded trial, was stopped early after combined estrogen-plus-progestin therapy was linked to more breast cancers than placebo. Headlines led millions of women to stop hormones, and many clinicians stopped prescribing them. If your mother or aunt quit her hormones overnight around then, this is why.

Later analyses added important nuance:

• Most WHI participants were in their 60s, on average more than 10 years past menopause, and didn't have bothersome hot flashes.
• The trial used specific products (oral conjugated estrogens and medroxyprogesterone acetate).
• The estrogen-only arm, in people without a uterus, did not show an increase in breast cancer.

What changed recently: In November 2025, the FDA announced it would remove breast cancer, cardiovascular disease and probable dementia from the boxed warning on menopausal hormone therapy labels, and it began approving those label changes in early 2026. The boxed warning about endometrial cancer for estrogen-only therapy in people who still have a uterus stays. A label change doesn't change the underlying research; it changes how the risk is presented. The conversation with your clinician still matters.

Estrogen alone vs. estrogen plus progestogen

You need the progestogen if you have a uterus, because estrogen alone can cause endometrial cancer. Researchers are still studying whether micronized progesterone carries a different breast risk than synthetic progestins; The Menopause Society says the evidence isn't settled yet.

How big is the risk, really?

The Menopause Society's 2022 position statement describes the absolute risk of breast cancer from combined hormone therapy as low. Many experts point out that common lifestyle factors, such as drinking alcohol regularly, being physically inactive or having obesity after menopause, also raise breast cancer risk.

What matters most is your baseline. A small relative increase means something very different to someone at low baseline risk than to someone with a strong genetic risk.

What your clinician will weigh:

• Your age and how long since menopause
• Personal history of breast biopsies with atypia
• Family history, including known BRCA or other gene variants
• Breast density on mammography
• Alcohol use, weight and activity level
• How long you plan to use hormones

"Breast cancer runs in my family. Is HRT off the table?"

Not automatically. The Menopause Society notes that observational data haven't shown a larger hormone-related increase in women with a family history. It's still worth a careful look at your personal risk.

If you carry a BRCA variant and had your ovaries removed early to reduce cancer risk, hormone therapy until about the average age of natural menopause is often considered, as long as you haven't had breast cancer. That's a specialized decision best made with your gynecologist and, ideally, a genetic counselor or high-risk breast specialist.

"I'm a breast cancer survivor. What can I use?"

Systemic hormone therapy (pills, patches, gels) is generally not recommended after breast cancer.

Vaginal dryness and pain with sex can be severe after cancer treatment, and many survivors say nobody asked them about it. The usual approach:

1. Non-hormonal vaginal moisturizers and lubricants
2. Pelvic floor physical therapy where helpful
3. If symptoms continue, low-dose vaginal estrogen may be considered after discussion with your oncologist, especially if you're not on an aromatase inhibitor

More in our guide to vaginal estrogen safety. For hot flashes, effective non-hormonal treatments exist.

Does stopping lower the risk?

The added risk linked to combined therapy appears to fall after stopping. Some long-term follow-up suggests a modest increase may linger for years in people who used it for a long time. That's one reason to review the decision regularly, say once a year, rather than avoid the topic.

Lowering your breast cancer risk, on hormones or off

• Limit alcohol. Even moderate drinking is linked to higher breast cancer risk.
• Stay active most days of the week.
• Maintain a healthy weight after menopause.
• Get screened. The USPSTF recommends mammograms every two years for women ages 40 to 74 at average risk. Some people need more frequent or additional imaging. In New York, mammogram reports tell you if you have dense breasts, which is worth discussing if you're on hormones.
• Know your family history and ask about genetic counseling if several relatives had breast, ovarian, pancreatic or prostate cancer.

If you're uninsured, New York's Cancer Services Program offers free screening mammograms to people who qualify.

Putting it in perspective

Hormone therapy decisions are about balance. For many healthy women in their 40s and 50s, untreated hot flashes and broken sleep hit work, mood and relationships hard, and hormone therapy also protects bone. The Menopause Society concludes that for most women under 60 or within 10 years of menopause, the overall benefits outweigh the risks. Our guide to menopause hormone therapy benefits and risks covers the full picture.

Questions to bring to your appointment

• Based on my history, is my baseline breast cancer risk average or higher than average?
• Do I need estrogen alone or estrogen plus a progestogen?
• Which form makes most sense for me (pill, patch, gel, spray)?
• How long do you expect I'll take it, and when will we review it?
• Would genetic counseling or a high-risk breast evaluation be useful?
• What mammogram schedule do you recommend while I'm on hormone therapy?
• If I decide against hormones, what are my best non-hormonal options?

There's rarely one "right" answer. A good clinician walks through the numbers with you and respects your preferences.

When to see a doctor

See your clinician if:

• You notice a new breast lump, skin dimpling, nipple changes or discharge
• You're deciding whether to start, continue or stop hormone therapy
• You have a strong family history of breast or ovarian cancer and want a risk assessment
• You're a breast cancer survivor with hot flashes or vaginal symptoms affecting your life

Search the directory for OB/GYNs and gynecologists across the five boroughs, Long Island and the Hudson Valley. When you call, ask whether the clinician regularly counsels patients on hormone therapy and breast cancer risk.

Frequently asked questions

Sources

• The Menopause Society — 2022 Hormone Therapy Position Statement
• NIH — Women's Health Initiative
• ACOG — Management of Menopausal Symptoms (Practice Bulletin 141)
• USPSTF — Breast Cancer: Screening
• National Cancer Institute — Menopausal Hormone Therapy and Cancer
• FDA — Menopausal hormone therapy labeling changes (announced November 2025)

This article is for general education and is not medical advice. It does not replace an evaluation by a licensed clinician who knows your history. If you think you have a medical emergency, call 911.